Log in to save to my catalogue

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1666293199

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

About this item

Full title

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Neurology, 2015-02, Vol.11 (2), p.80-89

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Key Points
Intravenous immunoglobulin (IVIg) is established for the treatment of several inflammatory neurological diseases, including Guillain–Barré syndrome, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, either as adjunctive or first-line therapy
IVIg was shown to be largely ineffective in Alzheimer dise...

Alternative Titles

Full title

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1666293199

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1666293199

Other Identifiers

ISSN

1759-4758

E-ISSN

1759-4766

DOI

10.1038/nrneurol.2014.253

How to access this item